![]() Galectin Therapeutics Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer. | ![]() Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. | |
Founding Date | Founding Date 2001 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Norcross, US HQ | Locations Cambridge, US HQ |
Employees | Employees 717% increase | Employees 2763% decrease |
Valuation ($) | Valuation ($) 155.1 m | Valuation ($) 223.7 m |
Financial | ||
Net income | Net income ($30.8m) (FY, 2025) | Net income ($1.2m) (FY, 2023) |

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
View company